21 CFR 211.196: Distribution records

Requires drug manufacturers to keep distribution records showing product name, strength, and dosage form, the consignee's name and address, the date and quantity shipped, and the lot or control number.

Part 211, Current Good Manufacturing Practice for Finished Pharmaceuticals · Subpart J, Records and Reports

How FDA words it

The opening lines investigators use most when they cite 211.196, from the 483s we hold.

Distribution records do not contain the lot or control number of drug product.Most used
Distribution records do not contain the name and strength of the drug product, description of dosage form, name and address of consignee, date and quantity shipped and lot or control number of drug product.

Recent 483s citing 211.196

See all 483s citing 211.196

The regulation text

§ 211.196 Distribution records.

Distribution records shall contain the name and strength of the product and description of the dosage form, name and address of the consignee, date and quantity shipped, and lot or control number of the drug product.

[89 FR 51770, June 18, 2024]

Questions

What does 21 CFR 211.196 require?

Requires drug manufacturers to keep distribution records showing product name, strength, and dosage form, the consignee's name and address, the date and quantity shipped, and the lot or control number.

How do FDA investigators word a 211.196 observation?

The most common opening is: “Distribution records do not contain the lot or control number of drug product.”

Which sections are cited alongside 211.196?

In the same 483s, investigators most often also cite 211.22 (Responsibilities of quality control unit), 211.188 (Batch production and control records), 211.198 (Complaint files), 211.192 (Production record review).